Frontiers in Preclinical Safety Biomarkers: MicroRNAs and Messenger RNAs

Toxicologic Pathology

Volumn 41, Issue 1, 2013, Pages 18-31

  Mikaelian, Igor ^a   Scicchitano, Marshall ^b   Mendes, Odete ^c   Thomas, Roberta A ^b   Leroy, Bruce E ^d  

^a HOFFMANN LA ROCHE INC   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Eurofins Medinet Inc   (Germany)

^d ABBOTT LABORATORIES   (United States)

Author keywords

biomarker; cardiotoxicity; hepatotoxicity; messenger RNA; microRNA; vascular injury

Indexed keywords

MESSENGER RNA; MICRORNA;

BLOOD VESSEL INJURY; BODY FLUID; CARDIOTOXICITY; GENE SILENCING; HUMAN; LIVER TOXICITY; MEDICAL LITERATURE; MOLECULAR BIOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; REVIEW; RNA BINDING; RNA PROCESSING; RNA SYNTHESIS; TOXICITY;

ANIMALS; BIOLOGICAL MARKERS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; MICRORNAS; RNA, MESSENGER;

EID: 84871667493     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312448939     Document Type: Article

References (179)

1. Ach R. A. Wang H. Curry B. (2008). Measuring microRNAs: Comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol 8, 69.
2. Ambros V. (2004). The functions of animal microRNAs. Nature 431, 350–55.
3. Arroyo J. D. Chevillet J. R. Kroh E. M. Ruf I. K. Pritchard C. C. Gibson D. F. Mitchell P. S. Bennett C. F. Pogosova-Agadjanyan E. L. Stirewalt D. L. Tait J. F. Tewari M. (2011). Argonaute 2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108, 5003–8.
4. Avissar M. Christensen B. C. Kelsey K. T. Marsit C. J. (2009). MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15, 2850–55.
5. Baffa R. Fassan M. Volinia S. O'Hara B. Liu C. G. Palazzo J. P. Gardiman M. Rugge M. Gomella L. G. Croce C. M. Rosenberg A. (2009). MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219, 214–21.
6. Bandiera S. Ruberg S. Girard M. Cagnard N. Hanein S. Chretien D. Munnich A. Lyonnet S. Henrion-Caude A. (2011). Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One 6, e20746.
7. Barrey E. Saint-Auret G. Bonnamy B. Damas D. Boyer O. Gidrol X. (2011). Pre-microRNA and mature microRNA in human mitochondria. Plos One, 6, e20220.
8. Bartel D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell 136, 215–33.
9. Bastida E. Ordinas A. Escolar G. Jamieson G. A. (1984). Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 64, 177–84.
10. Batliwalla F. M. Li W. Ritchlin C. T. Xiao X. Brenner M. Laragione T. Shao T. Durham R. Kemshetti S. Schwarz E. Coe R. Kern M. Baechler E. C. Behrens T. W. Gregersen P. K. Gulko P. S. (2005). Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol Med 11, 21–29.
11. Beaudoin A. R. Grondin G. (1991). Shedding of vesicular material from the cell surface of eukaryotic cells: Different cellular phenomena. Biochim Biophys Acta 1071, 203–19.
12. Becker C. Hammerle-Fickinger A. Riedmaier I. Pfaffl M. W. (2010). mRNA and microRNA quality control for RT-qPCR analysis. Methods 50, 237–43.
13. Benes V. Castoldi M. (2010). Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods 50, 244–49.
14. Berridge B. R. Pettit S. Walker D. B. Jaffe A. S. Schultze A. E. Herman E. Reagan W. J. Lipshultz S. E. Apple F. S. York M. J. (2009). A translational approach to detecting drug-induced cardiac injury with cardiac troponins: Consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute. Amer Heart J 158, 21–29.
15. Bianchi D. W. Maron J. L. Johnson K. L. (2010). Insights into fetal and neonatal development through analysis of cell-free RNA in body fluids. Early Hum Dev 86, 747–52.
16. Bissels U. Wild S. Tomiuk S. Holste A. Hafner M. Tuschl T. Bosio A. (2009). Absolute quantification of microRNAs by using a universal reference. RNA 15, 2375–2384.
17. Bonauer A. Boon R. A. Dimmeler S. (2010). Vascular microRNAs. Curr Drug Targets 11, 943–49.
18. Booij B. B. Lindahl T. Wetterberg P. Skaane N. V. Saebo S. Feten G. Rye P. D. Kristiansen L. I. Hagen N. Jensen M. Bardsen K. Winblad B. Sharma P. Lonneborg A. (2011). A gene expression pattern in blood for the early detection of Alzheimer's disease. J Alzheimers Dis 23, 109–19.
19. Brase J. C. Johannes M. Schlomm T. Falth M. Haese A. Steuber T. Beissbarth T. Kuner R. Sultmann H. (2011). Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128, 608–16.
20. Brase J. C. Wuttig D. Kuner R. Sultmann H. (2010). Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9, 306.
21. Bravo V. Rosero S. Ricordi C. Pastori R. L. (2007). Instability of miRNA and cDNAs derivatives in RNA preparations. Biochem Biophys Res Commun 353, 1052–55.
22. Brennecke J. Stark A. Russell R. B. Cohen S. M. (2005). Principles of microRNA-target recognition. PLoS Biol 3, e85.
23. Burchard J. Jackson A. L. Malkov V. Needham R. H. Tan Y. Bartz S. R. Dai H. Sachs A. B. Linsley P. S. (2009). MicroRNA-like off-target transcript regulation by siRNAs is species specific. RNA 15, 308–15.
24. Burczynski M. E. Dorner A. J. (2006). Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics 7, 187–202.
25. Calin G. A. Sevignani C. Dan Dumitru C. Hyslop T. Noch E. Yendamuri S. Shimizu M. Rattan S. Bullrich F. Negrini M. Croce C. M. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 101, 2999–3004.
26. Camps C. Buffa F. M. Colella S. Moore J. Sotiriou C. Sheldon H. Harris A. L. Gleadle J. M. Ragoussis J. (2008). hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14, 1340–48.
27. Care A. Catalucci D. Felicetti F. Bonci D. Addario A. Gallo P. Bang M. L. Segnalini P. Gu Y. Dalton N. D. Elia L. Latronico M. V. Hoydal M. Autore C. Russo M. A. Dorn G.W. II Ellingsen O. Ruiz-Lozano P. Peterson K. L. Croce C. M. Peschle C. Condorelli G. (2007). MicroRNA-133 controls cardiac hypertrophy. Nat Med 13, 613–18.
28. Chaput N. Schartz N. E. Andre F. Zitvogel L. (2003). Exosomes for immunotherapy of cancer. Adv Exp Med Biol 532, 215–21.
29. Chen C. Ridzon D. A. Broomer A. J. Zhou Z. Lee D. H. Nguyen J. T. Barbisin M. Xu N. L. Mahuvakar V. R. Andersen M. R. Lao K. Q. Livak K. J. Guegler K.J. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucl Acids Res, 33, e179.
30. Chen C. Skog J. Hsu C. H. Lessard R. T. Balaj L. Wurdinger T. Carter B. S. Breakefield X. O. Toner M. Irimia D. (2010). Microfluidic isolation, and transcriptome analysis of serum microvesicles. Lab Chip 10, 505–11.
31. Chen X. Ba Y. Ma L. Cai X. Yin Y. Wang K. Guo J. Zhang Y. Chen J. Guo X. Li Q. Li X. Wang W. Wang J. Jiang X. Xiang Y. Xu C. Zheng P. Zhang J. Li R. Zhang H. Shang X. Gong T. Ning G. Zen K. Zhang C.Y. (2008). Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997–1006.
32. Chen Y. Gorski D. H. (2008). Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111, 1217–26.
33. Cheng Y. Liu X. Yang J. Lin Y. Xu D. Z. Lu Q. Deitch E. A. Huo Y. Delphin E. S. Zhang C. (2009). MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105, 158–66.
34. Clements P. Brady S. York M. Berridge B. Mikaelian I. Nicklaus R. Gandhi M. Roman I. Stamp C. Davies D. McGill P. Williams T. Pettit S. Walker D. Turton J. (2010). Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat. Toxicol Pathol 38, 703–14.
35. Cocucci E. Racchetti G. Meldolesi J. (2009). Shedding microvesicles: Artefacts no more. Trends Cell Biol 19, 43–51.
36. Cordes K. R. Sheehy N. T. White M. P. Berry E. C. Morton S. U. Muth A. N. Lee T. H. Miano J. M. Ivey K. N. Srivastava D. (2009). miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705–10.
37. Cui W. Ma J. Wang Y. Biswal S. (2011). Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One 6, e22988.
38. D'Alessandra Y. Devanna P. Limana F. Straino S. Di Carlo A. Brambilla P. G. Rubino M. Carena M. C. Spazzafumo L. De Simone M. Micheli B. Biglioli P. Achilli F. Martelli F. Maggiolini S. Marenzi G. Pompilio G. Capogrossi M. C. (2010). Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31, 2765–73.
39. Daubman S. (2010). MicroRNAs in angiogenesis and vascular smooth muscle cell function. Circ Res 106, 423–25.
40. de Planell-Saguer M. Rodicio M. C. (2011). Analytical aspects of microRNA in diagnostics: A review. Anal Chim Acta 699, 134–52.
41. Diamandis E. P. (2010). Cancer biomarkers: Can we turn recent failures into success? J Natl Cancer Inst 102, 1462–67.
42. Dovc-Drnovsek T. Emersic B. Rozman P. Cerne D. Lukac-Bajalo J. (2008). Optimization of purification of human cell-free mRNA from plasma. Ann N Y Acad Sci 1137, 125–29.
43. Duttagupta R. Jiang R. Gollub J. Getts R. C. Jones K. W. (2011). Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6, e20769.
44. El-Hefnawy T. Raja S. Kelly L. Bigbee W. L. Kirkwood J. M. Luketich J. D. Godfrey T. E. (2004). Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 50, 564–73.
45. Engle S. K. Jordan W. H. Pritt M. L. Chiang A. Y. Davis M. A. Zimmermann J. L. Rudmann D. G. Heinz-Taheny K. M. Irizarry A. R. Yamamoto Y. Mendel D. Schultze A. E. Cornwell P. D. Watson D. E. (2009). Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development. Toxicol Pathol 37, 617–28.
46. Escrevente C. Keller S. Altevogt P. Costa J. (2011). Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer 11, 108.
47. Faller M. Guo F. (2008). MicroRNA biogenesis: There's more than one way to skin a cat. Biochim Biophys Acta 1779, 663–67.
48. Fasanaro P. D'Alessandra Y. Di Stefano V. Melchionna R. Romani S. Pompilio G. Capogrossi M. C. Martelli F. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283, 15878–83.
49. Fichtlscherer S. De Rosa S. Fox H. Schwietz T. Fischer A. Liebetrau C. Weber M. Hamm C. W. Roxe T. Muller-Ardogan M. Bonauer A. Zeiher A. M. Dimmeler S. (2010). Circulating microRNAs in patients with coronary artery disease. Circ Res 107, 677–84.
50. Fire A. Xu S. Q. Montgomery M. K. Kostas S. A. Driver S. E. Mello C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–11.
51. Gibbings D. J. Ciaudo C. Erhardt M. Voinnet O. (2009). Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11, 1143–49.
52. Gidlof O. Andersson P. van der Pals J. Gotberg M. Erlinge D. (2011). Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118, 217–26.
53. Gilad S. Meiri E. Yogev Y. Benjamin S. Lebanony D. Yerushalmi N. Benjamin H. Kushnir M. Cholakh H. Melamed N. Bentwich Z. Hod M. Goren Y. Chajut A. (2008). Serum microRNAs are promising novel biomarkers. PLoS One 3, e3148.
54. Gorgani N. N. Theofilopoulos A. N. (2007). Contribution of histidine-rich glycoprotein in clearance of immune complexes and apoptotic cells: Implications for ameliorating autoimmune diseases. Autoimmunity 40, 260–66.
55. Griffiths-Jones S. Grocock R. J. van Dongen S. Bateman A. Enright A. J. (2006). miRBase: MicroRNA sequences, targets and gene nomenclature. Nucl Acid Res 34, D140–44.
56. Grunblatt E. Bartl J. Zehetmayer S. Ringel T. M. Bauer P. Riederer P. Jacob C. P. (2009). Gene expression as peripheral biomarkers for sporadic Alzheimer's disease. J Alzheimers Dis 16, 627–34.
57. Gupta A. Mo Y. Y. (2011). Detection of microRNAs in cultured cells and paraffin-embedded tissue specimens by in situ hybridization. Met Mol Biol (Clifton, N.J) 676, 73–83.
58. Halicka H. D. Bedner E. Darzynkiewicz Z. (2000). Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res 260, 248–56.
59. Hammerle-Fickinger A. Riedmaier I. Becker C. Meyer H. H. Pfaffl M. W. Ulbrich S. E. (2010). Validation of extraction methods for total RNA and miRNA from bovine blood prior to quantitative gene expression analyses. Biotechnol Lett 32, 35–44.
60. Harris T. A. Yamakuchi M. Ferlito M. Mendell J. T. Lowenstein C. J. (2008). MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105, 1516–21.
61. Hausler S. F. Keller A. Chandran P. A. Ziegler K. Zipp K. Heuer S. Krockenberger M. Engel J. B. Honig A. Scheffler M. Dietl J. Wischhusen J. (2010). Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 103, 693–700.
62. H.H.G., Heijnen, A.E., Schiel, R., Fijnheer, H.J., Geuze, J.J., Sixma, Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α-Granules, Blood, (1999), 94, 3791-3799
63. Heneghan H. M. Miller N. Kelly R. Newell J. Kerin M. J. (2010). Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15, 673–82.
64. Hickman P. E. Potter J. M. Aroney C. Koerbin G. Southcott E. Wu A. H. Roberts M. S. (2010). Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta 411, 318–23.
65. Hirashima A. Sawaki S. Inokuchi Y. Inouye M. (1986). Engineering of the messenger-RNA-interfering complementary RNA immune-system against viral-infection. Proc Natl Acad Sci USA 83, 7726–30.
66. Holford N. C. Sandhu H. S. Thakkar H. Butt A. N. Swaminathan R. (2008). Stability of betàin mRNA in plasma. Ann N Y Acad Sci 1137, 108–11.
67. Huang L. Mollet S. Souquere S. Le Roy F. Ernoult-Lange M. Pierron G. Dautry F. Weil D. (2011). Mitochondria associate with p-bodies and modulate microrna-mediated RNA interference. J Biol Chem 286, 24219–30.
68. Jang J. S. Simon V. A. Feddersen R. M. Rakhshan F. Schultz D. A. Zschunke M. A. Lingle W. L. Kolbert C. P. Jen J. (2011). Quantitative miRNA expression analysis using fluidigm microfluidics dynamic arrays. BMC Genomics 12, 144.
69. Ji X. Takahashi R. Hiura Y. Hirokawa G. Fukushima Y. Ywai N. (2009). Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55, 1944–9.
70. Jorgensen S. Baker A. Moller S. Nielsen B.S. (2010). Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52, 375–81.
71. Jung M. Schaefer A. Steiner I. Kempkensteffen C. Stephan C. Erbersdobler A. Jung K. (2010). Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 56, 998–1006.
72. Kai Z. S. Pasquinelli A. E. (2010). MicroRNA assassins: Factors that regulate the disappearance of miRNAs. Nat Struct Mol Biol 17, 5–10.
73. Kannan M. Mohan K. V. Kulkarni S. Atreya C. (2009). Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis. Transfusion 49, 1443–50.
74. Keller A. Leidinger P. Borries A. Wendschlag A. Wucherpfennig F. Scheffler M. Huwer H. Lenhof H. P. Meese E. (2009). miRNAs in lung cancer — Studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9, 353.
75. Keller S. Ridinger J. Rupp A. K. Janssen J. W. Altevogt P. (2011). Body fluid derived exosomes as a novel template for clinical diagnostics. J Trans Med 9, 86.
76. Kiefer C. R. Snyder L. M. (2000). Oxidation and erythrocyte senescence. Curr Opin Hematol 7, 113–16.
77. Kim D. H. Saetrom P. Snove O. Jr Rossi J. J. (2008). MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci USA 105, 16230–35.
78. Kim V. N. Nam J. W. (2006). Genomics of microRNA. Trends in Genetics 22, 165–73.
79. Konopka W. Kiryk A. Novak M. Herwerth M. Parkitna J. R. Wawrzyniak M. Kowarsch A. Michaluk P. Dzwonek J. Arnsperger T. Wilczynski G. Merkenschlager M. Theis F. J. Kohr G. Kaczmarek L. Schutz G. (2010). MicroRNA loss enhances learning and memory in mice. J Neurosci 30, 14835–842.
80. Kosaka N. Iguchi H. Ochiya T. (2010a). Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101, 2087–92.
81. Kosaka N. Iguchi H. Yoshioka Y. Takeshita F. Matsuki Y. Ochiya T. (2010b). Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285, 17442–52.
82. Kroh E. M. Parkin R. K. Mitchell P. S. Tewari M. (2010). Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298–301.
83. Krol J. Busskamp V. Markiewicz I. Stadler M. B. Ribi S. Richter J. Duebel J. Bicker S. Fehling H. J. Schübeler D. Oertner T. G. Schratt G. Bibel M. Roska B. Filipowicz W. (2010a). Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 141, 618–31.
84. Krol J. Loedige I. Filipowicz W. (2010b). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11, 597–610.
85. Kudo Y. Ochi T. Shimada H. Ogawa S. Shinjo K. (2008). Utility of plasma circulating mRNA as a marker to detect hepatic injury. J Vet Med Sci 70, 993–95.
86. Kuehbacher A. Urbich C. Zeiher A. M. Dimmeler S. (2007). Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101, 59–68.
87. Kuhnert F. Mancuso M. R. Hampton J. Stankunas K. Asano T. Chen C. Z. Kuo C. J. (2008). Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135, 3989–993.
88. Kulkarni M. Ozgur S. Stoecklin G. (2010). On track with P-bodies. Biochem Soc Trans 38, 242–51.
89. Lasser C. Alikhani V. S. Ekstrom K. Eldh M. Paredes P. T. Bossios A. Sjostrand M. Gabrielsson S. Lotvall J. Valadi H. (2011). Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages. J Trans Med 9, 9.
90. Laterza O. F. Lim L. Garrett-Engele P. W. Vlasakova K. Muniappa N. Tanaka W. K. Johnson J. M. Sina J. F. Fare T. L. Sistare F. D. Glaab W. E. (2009). Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55, 1977–83.
91. Lee T. H. D'Asti E. Magnus N. Al-Nedawi K. Meehan B. Rak J. (2011). Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular ‘debris'. Semin Immunopathol. 33, 455–67.
92. Li D. Butt A. Clarke S. Swaminathana R. (2004a). Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects. Ann N Y Acad Sci 1022, 147–51.
93. Li T. Cao H. Zhuang J. Wan J. Guan M. Yu B. Li X. Zhang W. (2011). Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 412, 66–70.
94. Li Y. Zhou X. St John M. A. Wong D. T. (2004b). RNA profiling of cell-free saliva using microarray technology. J Dent Res 83, 199–203.
95. Liangos O. Domhan S. Schwager C. Zeier M. Huber P. E. Addabbo F. Goligorsky M. S. Hlatky L. Jaber B. L. Abdollahi A. (2010). Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS One 5, e13658.
96. Liew C. C. Ma J. Tang H. C. Zheng R. Dempsey A. A. (2006). The peripheral blood transcriptome dynamically reflects system wide biology: A potential diagnostic tool. J Lab Clin Med 147, 126–32.
97. Liu J. Valencia-Sanchez M. A. Hannon G. J. Parker R. (2005). MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7, 719–23.
98. Liu X. Cheng Y. Zhang S. Lin Y. Yang J. Zhang C. (2009). A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104, 476–87.
99. Lodes M. J. Caraballo M. Suciu D. Munro S. Kumar A. Anderson B. (2009). Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 4, e6229.
100. Losche W. Scholz T. Temmler U. Oberle V. Claus R.A. (2004). Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets 15, 109–15.
101. Lotvall J. Valadi H. (2007). Cell to cell signalling via exosomes through esRNA. Cell Adh Migr 1, 156–58.
102. Luo X. Burwinkel B. Tao S. Brenner H. (2011). MicroRNA signatures: Novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev 20, 1272–86.
103. McCall M. N. Kent O. A. Yu J. Fox-Talbot K. Zaiman A. L. Halushka M. K. (2011). MicroRNA profiling of diverse endothelial cell types. BMC Med Genomics 4, 78.
104. Meder B. Keller A. Vogel B. Haas J. Sedaghat-Hamedani F. Kayvanpour E. Just S. Borries A. Rudloff J. Leidinger P. Meese E. Katus H. A. Rottbauer W. (2011). MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 106, 13–23.
105. Mendrick D. L. (2011). Transcriptional profiling to identify biomarkers of disease and drug response. Pharmacogenomics 12, 235–49.
106. Merchant M. L. Powell D. W. Wilkey D. W. Cummins T. D. Deegens J. K. Rood I. M. McAfee K. J. Fleischer C. Klein E. Klein J.B. (2010). Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin Appl 4, 84–96.
107. Mestdagh P. Lefever S. Pattyn F. Ridzon D. Fredlund E. Fieuw A. Ongenaert M. Vermeulen J. De Paepe A. Wong L. Speleman F. Chen C. Vandesompele J. (2011). The microRNA body map: Dissecting microRNA function through integrative genomics. Nucl Acids Res 39, e136.
108. Miranda K. C. Huynh T. Tay Y. Ang Y.-S. Tam W.-L. Thomson A. M. Lim B. Rigoutsos I. (2006). A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203–17.
109. Miska E. A. (2005). How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15, 563–68.
110. Mitchell P. S. Parkin R. K. Kroh E. M. Fritz B. R. Wyman S. K. Pogosova-Agadjanyan E. L. Peterson A. Noteboom J. O'Briant K. C. Allen A. Lin D. W. Urban N. Drescher C. W. Knudsen B. S. Stirewalt D. L. Gentleman R. Vessella R. L. Nelson P. S. Martin D. B. Tewari M. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513–518.
111. Mittelbrunn M. Gutierrez-Vazquez C. Villarroya-Beltri C. Gonzalez S. Sanchez-Cabo F. Gonzalez M. A. Bernad A. Sanchez-Madrid F. (2011). Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2, 282.
112. Mohla S. Zhang H. G. Dhodapkar M. Howcroft T. K. (2011). Vesicle transfer and cell fusion: Emerging concepts of cell-cell communication in the tumor microenvironment. Cancer Biol Ther, 12, 159–64.
113. Morse M. A. Garst J. Osada T. Khan S. Hobeika A. Clay T. M. Valente N. Shreeniwas R. Sutton M. A. Delcayre A. Hsu D. H. Le Pecq J. B. Lyerly H. K. (2005). A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3, 9.
114. Mraz M. Malinova K. Mayer J. Pospisilova S. (2009). MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun 390, 1–4.
115. Muller O. Delrue L. Hamilos M. Vercauteren S. Ntalianis A. Trana C. Mangiacapra F. Dierickx K. De Bruyne B. Wijns W. Behfar A. Barbato E. Terzic A. Vanderheyden M. Bartunek J. (2011). Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction. EuroIntervention 7, 458–66.
116. Murchison E. P. Hannon G.J. (2004). miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol 16, 223–29.
117. Ng E. K. Chong W. W. Jin H. Lam E. K. Shin V. Y. Yu J. Poon T. C. Ng S. S. Sung J. J. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 58, 1375–81.
118. Nuovo G. J. (2010). In situ detection of microRNAs in paraffin embedded, formalin fixed tissues and the co-localization of their putative targets. Methods 52, 307–15.
119. Olive V. Jiang I. He L. (2010). mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42, 1348–54.
120. Orozco A. F. Lewis D.E. (2010). Flow cytometric analysis of circulating microparticles in plasma. Cytometry Part A 77A, 502–14.
121. Pegtel D. M. Cosmopoulos K. Thorley-Lawson D. A. van Eijndhoven M. A. Hopmans E. S. Lindenberg J. L. de Gruijl T. D. Wurdinger T. Middeldorp J. M. (2010). Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107, 6328–33.
122. Peltier H. J. Latham G.J. (2008). Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14, 844–52.
123. Pena J. T. Sohn-Lee C. Rouhanifard S. H. Ludwig J. Hafner M. Mihailovic A. Lim C. Holoch D. Berninger P. Zavolan M. Tuschl T. (2009). miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat Methods 6, 139–141.
124. Pereira J. Palomo I. Ocqueteau M. Soto M. Aranda E. Mezzano D. (1999). Platelet aging in vivo is associated with loss of membrane phospholipid asymmetry. Thromb Haemost 82, 1318–21.
125. Portnoy V. Huang V. Place R. F. Li L. C. (2011). Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA 2, 748–60.
126. Quesenberry P. J. Aliotta J. M. (2010). Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev 62, 1141–48.
127. Ramachandran V. Chen X. (2008). Degradation of microRNAs by a family of exoribonucleases in Arabidopsis. Science 321, 1490–92.
128. Resnick K. E. Alder H. Hagan J. P. Richardson D. L. Croce C. M. Cohn D. E. (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112, 55–59.
129. Reynier F. Pachot A. Paye M. Xu Q. Turrel-Davin F. Petit F. Hot A. Auffray C. Bendelac N. Nicolino M. Mougin B. Thivolet C. (2010). Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Genes Immun 11, 269–78.
130. Roberts J. (2009). C-Path sets diagnostics standard. Nat Biotechnol 27, 213.
131. Rosa A. Spagnoli F. M. Brivanlou A. H. (2009). The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell 16, 517–27.
132. Roth P. Wischhusen J. Happold C. Chandran P. A. Hofer S. Eisele G. Weller M. Keller A. (2011). A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem, 118, 449–57.
133. Sangokoya C. LaMonte G. Chi J. T. (2010). Isolation and characterization of microRNAs of human mature erythrocytes. Meth Mol Biol (Clifton, N.J.) 667, 193–203.
134. Schmidt M. Paes K. De Maziere A. Smyczek T. Yang S. Gray A. French D. Kasman I. Klumperman J. Rice D. S. Ye W. (2007). EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 134, 2913–23.
135. Shen J. Todd N. W. Zhang H. Yu L. Lingxiao X. Mei Y. Guarnera M. Liao J. Chou A. Lu C. L. Jiang Z. Fang H. Katz R. L. Jiang F. (2011). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91, 579–87.
136. Sims P. J. Faioni E. M. Wiedmer T. Shattil S. J. (1988). Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263, 18205–212.
137. Singh P. P. LeMaire C. Tan J. C. Zeng E. Schorey J. S. (2011). Exosomes released from M. tuberculosis infected cells can suppress IFN-gamma mediated activation of naive macrophages. Plos One 6, e18564.
138. Sistare F. D. Dieterle F. Troth S. Holder D. J. Gerhold D. Andrews-Cleavenger D. Baer W. Betton G. Bounous D. Carl K. Collins N. Goering P. Goodsaid F. Gu Y. Z. Guilpin V. Harpur E. Hassan A. Jacobson-Kram D. Kasper P. Laurie D. Lima B. S. Maciulaitis R. Mattes W. Maurer G. Obert L. A. Ozer J. Papaluca-Amati M. Phillips J. A. Pinches M. Schipper M. J. Thompson K. L. Vamvakas S. Vidal J. M. Vonderscher J. Walker E. Webb C. Yu Y. (2010). Towards consensus practices to qualify safety biomarkers for use in early drug development. Nat Biotechnol 28, 446–54.
139. Starkey Lewis P. J. Dear J. Platt V. Simpson K. J. Craig D. G. Antoine D. J. French N. S. Dhaun N. Webb D. J. Costello E. M. Neoptolemos J. P. Moggs J. Goldring C. E. Park B. K. (2011). Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54, 1767–76.
140. Sukata T. Sumida K. Kushida M. Ogata K. Miyata K. Yabushita S. Uwagawa S. (2011). Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol Lett 200, 46–52.
141. Sutherland A. Thomas M. Brandon R. A. Brandon R. B. Lipman J. Tang B. McLean A. Pascoe R. Price G. Nguyen T. Stone G. Venter D. (2011). Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care 15, R149.
142. Tan F. K. Zhou X. Mayes M. D. Gourh P. Guo X. Marcum C. Jin L. Arnett F. C., Jr (2006). Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 45, 694–702.
143. Tan K. S. Armugam A. Sepramaniam S. Lim K. Y. Setyowati K. D. Wang C. W. Jeyaseelan K. (2009). Expression profile of MicroRNAs in young stroke patients. PLoS One, 4, e7689.
144. Tanzer A. Stadler P. F. (2004). Molecular evolution of a microRNA cluster. J Mol Biol 339, 327–335.
145. Taylor D. D. Homesley H. D. Doellgast G. J. (1980). Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. Canc Res 40, 4064–69.
146. Taylor D. D. Zacharias W. Gercel-Taylor C. (2011). Exosome isolation for proteomic analyses and RNA profiling. Meth Mol Biol (Clifton, N.J.), 728, 235–46.
147. Thery C. Ostrowski M. Segura E. (2009). Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9, 581–93.
148. Thery C. Zitvogel L. Amigorena S. (2002). Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2, 569–79.
149. R.A., Thomas, M.S., Scicchitano, R.C., Mirabile, N.T., Chau, K.S., Frazier, H.C., Thomas, microRNA changes in rat mesentery and serum associated with drug-induced vascular injury. Accepted, Toxicol Applied Pharmacol, in press. DOI: 10.1016/j.taap.2012.05.009, (2012)
150. Thomson D. W. Bracken C. P. Goodall G.J. (2011). Experimental strategies for microRNA target identification. Nucl Acids Res 39, 6845–53.
151. Trams E. G. Lauter C. J. Salem N. Jr Heine U. (1981). Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 645, 63–70.
152. Tsui N. B. Ng E. K. Lo Y. M. (2002). Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 48, 1647–53.
153. Turchinovich A. Weiz L. Langheinz A. Burwinkel B. (2011). Characterization of extracellular circulating microRNA. Nucl Acids Res 39, 7723–33.
154. Valadi H. Ekstrom K. Bossios A. Sjostrand M. Lee J. J. Lotvall J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9, 654–59.
155. van Rooij E. Quiat D. Johnson B. A. Sutherland L. B. Qi X. Richardson J. A. Kelm R. J. Jr Olson E. N. (2009). A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17, 662–73.
156. van Rooij E. Sutherland L. B. Liu N. Williams A. H. McAnally J. Gerard R. D. Richardson J. A. Olson E. N. (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103, 18255–260.
157. van Solingen C. Seghers L. Bijkerk R. Duijs J. M. Roeten M. K. van Oeveren-Rietdijk A. M. Baelde H. J. Monge M. Vos J. B. de Boer H. C. Quax P. H. Rabelink T. J. van Zonneveld A. J. (2009). Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 13, 1577–85.
158. Vickers K. C. Palmisano B. T. Shoucri B. M. Shamburek R. D. Remaley A. T. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13, 423–33.
159. Wang G. K. Zhu J. Q. Zhang J. T. Li Q. Li Y. He J. Qin Y. W. Jing Q. (2010a). Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31, 659–66.
160. Wang K. Zhang S. Marzolf B. Troisch P. Brightman A. Hu Z. Hood L. E. Galas D. J. (2009). Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106, 4402–7.
161. Wang K. Zhang S. Weber J. Baxter D. Galas D. J. (2010b). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucl Acid Res 38, 7248–59.
162. Wang S. Aurora A. B. Johnson B. A. Qi X. McAnally J. Hill J. A. Richardson J. A. Bassel-Duby R. Olson E. N. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15, 261–71.
163. Wang Y. Li Y. Ma Z. Yang W. Ai C. (2010c). Mechanism of MicroRNA-target interaction: Molecular dynamics simulations and thermodynamics analysis. PLoS Comput Biol 6, e1000866.
164. Watson A. K. Witwer K. W. (2012). Do platform-specific factors explain microRNA profiling disparities? Clin Chem 58, 472–74.
165. Weber J. A. Baxter D. H. Zhang S. Huang D. Y. Huang K. H. Lee M. J. Galas D. J. Wang K. (2010). The microRNA spectrum in 12 body fluids. Clin Chem 56, 1733–41.
166. Wetmore B. A. Brees D. J. Singh R. Watkins P. B. Andersen M. E. Loy J. Thomas R. S. (2010). Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology 51, 2127–39.
167. Widera C. Gupta S. K. Lorenzen J. M. Bang C. Bauersachs J. Bethmann K. Kempf T. Wollert K. C. Thum T. (2011). Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 51, 872–5.
168. Wienholds E. Kloosterman W. P. Miska E. Alvarez-Saavedra E. Berezikov E. de Bruijn E. Horvitz H. R. Kauppinen S. Plasterk R. H. (2005). MicroRNA expression in zebrafish embryonic development. Science 309, 310–11.
169. Winter J. Jung S. Keller S. Gregory R. I. Diederichs S. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11, 228–34.
170. Wong A. Merritt S. Butt A. N. Williams A. Swaminathan R. (2008). Effect of hypoxia on circulating levels of retina-specific messenger RNA in type 2 diabetes mellitus. Ann NY Acad Sci 1137, 243–52.
171. Xu S. Witmer P. D. Lumayag S. Kovacs B. Valle D. (2007). MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem 282, 25053–66.
172. Yang X. Greenhaw J. Shi Q. Su Z. Qian F. Davis K. Mendrick D. L. Salminen W. F. (2012). Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol Sci 125, 335–44.
173. Yokota M. Tatsumi N. Nathalang O. Yamada T. Tsuda I. (1999). Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal 13, 133–40.
174. Zampetaki A. Kiechl S. Drozdov I. Willeit P. Mayr U. Prokopi M. Mayr A. Weger S. Oberhollenzer F. Bonora E. Shah A. Willeit J. Mayr M. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107, 810–17.
175. Zen K. Zhang C.Y. (2010). Circulating MicroRNAs: A novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev.
176. Zhang C. (2009). MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease. Cell Cycle 8, 3469–73.
177. Zhang F. Sun S. Feng D. Zhao W. L. Sui S. F. (2009). A novel strategy for the invasive toxin: Hijacking exosome-mediated intercellular trafficking. Traffic 10, 411–24.
178. Zhang Y. Jia Y. Zheng R. Guo Y. Wang Y. Guo H. Fei M. Sun S. (2010). Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56, 1830–38.
179. Zimmerman G. A. Weyrich A. S. (2008). Signal-dependent protein synthesis by activated platelets: New pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 28, s17–24.